Gastroenterology - European Medical Journal

Continue

Gastroenterology

Filter
27 Oct 2023

The New Era of Inflammatory Disease Treatment: Anti-TNF Adalimumab Biosimilars

This News Feature explores the impact of anti-TNF biosimilars on global healthcare as a cost-effective solution, enhancing access to treatment options for inflammatory conditions.
26 Oct 2023

The Enduring Potential of Anti-TNF Therapies: Insights from UEG Week 2023

This News Feature explores the approaches for optimising anti-TNF therapies in gastroenterology, based on content delivered during UEG…
16 Oct 2023

Increased Risk for Oesophageal Cancer After Anti-Reflux Surgery

Despite anti-reflux surgery being recommended for patients with Barrett’s oesophagus in order to decrease the risk of later developing oesophageal adenocarcinoma, recent research suggests that it may be no more effective than anti-reflux medication.
16 Oct 2023

Alcohol Does Not Affect Virologic Response in Hepatitis C Virus

Recent research has shown that alcohol use during the early stages of direct-acting antiviral treatment was not linked to reduced odds for achieving sustained virologic response (SVR) in patients with chronic HCV infection.
28 Sep 2023

How Stress Can Impact Inflammatory Bowel Disease

This News Feature explores the role of psychological stress in exacerbating inflammatory bowel disease, and offers insights into mind–body care to empower patients.
27 Sep 2023

Controversies in the Management of Inflammatory Bowel Disease with Anti-TNF Therapies

This News Feature discusses the role of anti-TNF therapies in treating inflammatory bowel disease (IBD), highlighting their impact…
18 Sep 2023

Effects of Positive Airway Pressure on Gastro-Oesophageal Reflux

Obstructive sleep apnoea is often accompanied by nocturnal gastro-oesophageal reflux. Recent studies show consistent use of positive airway pressure may decrease the odds for nGOR. Read more.
15 Sep 2023

Should Links between Gastrointestinal Issues and Parkinson’s Disease Raise Concern?

Studies have shown that dysphasia, gastroparesis, and irritable bowel syndrome without diarrhoea may come with an increased risk of later developing the Parkinson’s disease. Read more.